To the best of our knowledge, this study is the first to evaluate the effects of WBC treatments on adhesive molecules (soluble VCAM-1 and P-Selectin), neopterin, and albumin levels, as well as PON-1 activity, in patients with ankylosing spondylitis. Here, PON1 is linked to ankylosing spondylitis.